Westfuller Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11K Buy
60
+1
+2% +$184 ﹤0.01% 428
2025
Q4
$10.4K Buy
59
+33
+127% +$5.39K ﹤0.01% 464
2025
Q3
$3.64K Buy
+26
New +$3.51K ﹤0.01% 574

Other funds holding BIIB

Westfuller Advisors's BIIB Position: Q1 2026 in Review

Westfuller Advisors increased its Biogen (BIIB) stake by 1.7% in Q1 2026, buying an estimated $184 and bringing the position to 60 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Westfuller Advisors first reported a position in BIIB in Q3 2025 and has held it in 3 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Westfuller Advisors held 60 shares of Biogen worth $11K as of Q1 2026.
  • Westfuller Advisors bought 1 Biogen share in Q1 2026, an estimated $184.
  • Biogen made up ﹤0.01% of Westfuller Advisors's portfolio in Q1 2026, its #428 holding.
  • Westfuller Advisors first reported a position in Biogen in Q3 2025 and has held it in 3 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Westfuller Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.